Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

Agreement with Bayer Diagnostics allowing German firm to develop and distribute in vitro diagnostic tests based on Luminex' xMAP multi-analyte technology includes a multi-year deal for developing a new cellular analyzer. For the license agreement, Bayer will pay Luminex a one-time fee along with royalties once the tests are commercialized. Bayer will develop and sell the new flow cytometry analyzer for monitoring immunological status and blood disease, while Luminex will manufacture the product...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts